Skip to content

LENAPHARM PHARMACIE

Active Private limited companyfounded 2006active for 20 yearsGeneraal Jacqueslaan 42, 1050 IxellesKBO/BCE: BE 0880.705.956

Lifetime

19 annual accounts with figures on one time axis
peak of €241,201 in 2023
€151,233▼ 37.3%
peak of €136,404 in 2023
€47,549▼ 65.1%
peak of €512,274 in 2024
€512,274▲ 10.2%
€1.0m▼ 8.5%
peak of 1.2 FTE in 2014
-not published
Board2 names since 2025
- 
Documentsfilings and deeds
18-10-202579 days late
2024micro format
Gross margin from €241,201 to €151,233Result from €136,404 to €47,549Cash from €40,871 to €2,129

Key points

from the 2024 annual accounts

Equity

€512,274 ▲ 10.2%

LENAPHARM PHARMACIE has made a profit in every financial year since 2006.

Result

€47,549 ▼ 65.1%
€136,0002023€47,5002024

The result fell in 2024 from €136,404 to €47,549.

Turnover

≈ €530,000 estimated

The accounts state no turnover.

Filings

19 annual accounts 113 days past the deadline
AprilJune31 JulyOctober201020152020

2025 accounts not filed: deadline was 31-07-2026.

Position in the sector

€512,274

More equity than 95% of companies in retail trade. The sector median is €39,135, over 25,670 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 14,773 companies had the same profile as LENAPHARM PHARMACIE has now. Each dot stands for 37 companies, two years later.

96.2%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 14,773 companies, not a prediction for LENAPHARM PHARMACIE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

acts as permanent representative General meeting of 09-04-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0880705956
(director) and (director) appointed General meeting of 01-02-2025 · Gazette deed
Company renamed from PHARMACIE DHAHIB to LENAPHARM PHARMACIE Registered office moved from Vaux-Sous-Chèvremont to Ixelles · The registered office moved from Rue Vallée 59, 4051 Vaux-Sous-Chèvremont (Chaudfontaine) to Boulevard Général Jacques 42 boîte 1, 1050 Ixelles · resigns as manager · General meeting of 21-08-2014 · Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company
LENAPHARM PHARMACIE Ixelles €1.6m €151,233 32.9% -
PHARMACIE MOENS - JEHOULET Ciney €1.5m €150,109 75.8% 2.4
GEASSOCIEERDE APOTHEEK MARKGRAVE Antwerp €1.6m €170,360 8.9% 2.1
PHARMACIE CONSOLATION Schaerbeek €1.5m €171,769 81.1% 3.2
GOFRAN Zonhoven €1.7m €136,176 82.3% -
Pharmacie Pierret-Ducoffre Libramont-Chevigny €1.7m €181,949 32.8% 0
MINNEN-LUYTEN Herentals €1.3m €159,604 56.7% 0.1

These companies have the same main activity as LENAPHARM PHARMACIE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.3m and €1.7m, founded between 2004 and 2008.

Official details

Source: KBO
Status
Active since 13-04-2006Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.153.148.3921070 Anderlecht, since 27-04-2006
Financial year end
31 December
Peppol
Reachable since 14-11-2025
Company details

Annual accounts 2024

€1.6m▼ 3.1%
Filing
Filed on 18-10-2025
Financials

Insights on LENAPHARM PHARMACIE

LENAPHARM PHARMACIE files the micro format. That format states no turnover. The gross margin rose from €60,661 in 2006 to €151,233 in 2024.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about LENAPHARM PHARMACIE

What is the company number of LENAPHARM PHARMACIE?
The company number of LENAPHARM PHARMACIE is 0880.705.956. The VAT number is the same number with BE in front: BE 0880.705.956.
Where is LENAPHARM PHARMACIE based?
The registered office is at Generaal Jacqueslaan 42, 1050 Ixelles.Company details
What does LENAPHARM PHARMACIE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of LENAPHARM PHARMACIE?
LENAPHARM PHARMACIE is a private limited company (BV).
When was LENAPHARM PHARMACIE founded?
LENAPHARM PHARMACIE was founded on 13-04-2006.
Is LENAPHARM PHARMACIE still active?
Yes, LENAPHARM PHARMACIE is an active enterprise in the KBO register.
What is the turnover of LENAPHARM PHARMACIE?
The turnover in financial year 2024 is about €530,000. This figure is estimated from the gross margin of €151,233 and 37 comparable companies (NACE 477). It probably lies between €400,000 and €890,000.Financials
Is LENAPHARM PHARMACIE profitable?
In financial year 2024, LENAPHARM PHARMACIE made a profit of €47,549.
Where can I find the annual accounts of LENAPHARM PHARMACIE?
LENAPHARM PHARMACIE filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
When are the next annual accounts of LENAPHARM PHARMACIE due?
LENAPHARM PHARMACIE had to file the annual accounts for financial year 2025 by 31-07-2026. On 21-11-2026 they are not filed yet, 113 days past the deadline.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.